Angiogenesis - still a worthwhile target for breast cancer therapy?

Breast Cancer Res. 2010 Dec 20;12 Suppl 4(Suppl 4):S19. doi: 10.1186/bcr2748.
No abstract available

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Angiogenesis Inhibitors / therapeutic use*
  • Animals
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Calcium-Binding Proteins
  • Female
  • Humans
  • Hypoxia-Inducible Factor 1 / metabolism
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Mice
  • Neovascularization, Pathologic*
  • Pericytes
  • Polymorphism, Single Nucleotide
  • Signal Transduction
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Calcium-Binding Proteins
  • DLL4 protein, human
  • Hypoxia-Inducible Factor 1
  • Intercellular Signaling Peptides and Proteins
  • Vascular Endothelial Growth Factor A
  • Bevacizumab